Wednesday, July 14, 2010

Cyberheart Inc's patents

background:

Accuray Enters Licensing Agreement with CyberHeart Incorporated

Sunnyvale, California, April 30, 2007 – Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that it has entered into an agreement with CyberHeart Incorporated under which CyberHeart will use Accuray’s technology to develop a non-invasive method for performing cardiac ablation. Cardiac ablation is used to destroy a small portion of the heart that is causing abnormal rhythms. Ultimately, the developed technology may have applications in the treatment of atrial fibrillation, a disorder that prevents the heart from beating properly and can cause blood clots and strokes.

CyberHeart has received commitments for independent venture capital financing to fund technical and clinical research and development of a cardiac ablation system that incorporates Accuray’s technology. In the event CyberHeart is able to successfully develop and commercialize such a system, under Accuray’s agreement with CyberHeart, Accuray will be the sole supplier of radiosurgery equipment to CyberHeart and will also be entitled to receive specified payments based on usage of the CyberHeart system.

a post by yyy60:

20100160775 System For Non-Invasive Heart Treatment - non-invasive method for treatment of arrhythmia 06-24-2010
http://www.faqs.org/patents/app/20100160...


20100137709 Test Object For The Validation of Tracking In The Presence of Motion 06-03-2010
http://www.faqs.org/patents/app/20100137...


20090257557 Radiation Treatment Planning and Delivery for Moving Targets in the Heart 10-15-2009
http://www.faqs.org/patents/app/20090257...


20090080610 Radiosurgical Ablation of the Myocardium 03-26-2009
http://www.faqs.org/patents/app/20090080...


20080317204 Radiation treatment planning and delivery for moving targets in the heart 12-25-2008
http://www.faqs.org/patents/app/20080317...

No comments: